Displaying 1 - 12 of 20
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Addressing NASH as a chronic metabolic disease: the need for a simplified patient referral pathway

Webcasts
View
Metabolism, Alcohol & Toxicity

Simplifying the patient referral pathway in NASH: expert opinion

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion and Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and conclusion

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 1: Identifying Patients with NASH and Significant Fibrosis: Are we doing enough?

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 2: Managing patients with NASH and Significant Fibrosis – Now and in the future

Webcasts
View
Metabolism, Alcohol & Toxicity

Session 3: Treating patients with NASH and Significant Fibrosis, what the future holds?

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Panel Q/A

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introduction to the Event and Keynote Speakers

Webcasts
View
Displaying 1 - 12 of 20